D-dimer Testing Market to Reach US$ 2,269.31 Million by 2032 Supported by Growing Thromboembolic Disease Burden and Expansion of Point-of-Care Diagnostics Says Astute Analytica

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.
Labroots

D-Dimer: A routine assay with unique challenges

Venous thromboembolism (VTE) is a common disease that affects as many as 900,000 Americans yearly with an estimated 60,000 - 100,000 Americans dying each year as a result of VTE. D-Dimer levels ...